Just to remind everyone -- once again -- that the Harper government ignores science and research and the harm reduction model in favour of ideology.
Of course, if you don't think saving lives is important, or that some people's lives are worth less than others, this is irrelevant.
Vancouver Sun April 18, 2011:
Will dramatic drop in overdose deaths be enough to save Insite?
Despite indisputable proof that supervised injection site has saved countless lives, federal government forges ahead with bid to shut it down
When Insite, Vancouver's supervised injection site, opened in the fall of 2003, critics set for it what seemed an impossible task: The facility could not be considered a success, they argued, unless it represented a cost-effective way of increasing drug users' use of detox and treatment services, reducing needle sharing and public disorder and, perhaps most important of all, reducing overdose deaths.
In the first few years of its existence, Insite surprised nearly everyone by satisfying virtually all of these criteria. And better yet, it did this while attracting the drug users who are at the highest risk of overdose and HIV-infection, as well as many of the hardest to reach addicts.
But there was one thing that had yet to be confirmed -the reduction in overdose deaths, the very thing many critics believed to be the single most important criterion. One can, of course, debate whether it really is the most important criterion, since by increasing users' uptake of treatment services, Insite is undoubtedly saving lives, and increasing the quality of the lives it saves.
But treatment takes time, and we don't usually see what becomes of people who enter a treatment facility. Overdoses, on the other hand, provide an immediate and dramatic example of a life-or-death situation, and it's therefore difficult to deny the worth of a facility that prevents overdose deaths.
It's surprising, then, that despite the existence of some 65 supervised injection facilities throughout the world, there has been little solid research assessing the sites' ability to prevent overdose deaths. Fortunately, though, the prestigious medical journal The Lancet has today published a paper by researchers at the B.C. Centre for Excellence in HIV/AIDS, and the paper provides precisely the evidence we need.
See full story:
http://www.vancouversun.com/Will+dramatic+drop+overdose+deaths+enough+save+Insite/4632871/story.html
Of course, if you don't think saving lives is important, or that some people's lives are worth less than others, this is irrelevant.
Vancouver Sun April 18, 2011:
Will dramatic drop in overdose deaths be enough to save Insite?
Despite indisputable proof that supervised injection site has saved countless lives, federal government forges ahead with bid to shut it down
When Insite, Vancouver's supervised injection site, opened in the fall of 2003, critics set for it what seemed an impossible task: The facility could not be considered a success, they argued, unless it represented a cost-effective way of increasing drug users' use of detox and treatment services, reducing needle sharing and public disorder and, perhaps most important of all, reducing overdose deaths.
In the first few years of its existence, Insite surprised nearly everyone by satisfying virtually all of these criteria. And better yet, it did this while attracting the drug users who are at the highest risk of overdose and HIV-infection, as well as many of the hardest to reach addicts.
But there was one thing that had yet to be confirmed -the reduction in overdose deaths, the very thing many critics believed to be the single most important criterion. One can, of course, debate whether it really is the most important criterion, since by increasing users' uptake of treatment services, Insite is undoubtedly saving lives, and increasing the quality of the lives it saves.
But treatment takes time, and we don't usually see what becomes of people who enter a treatment facility. Overdoses, on the other hand, provide an immediate and dramatic example of a life-or-death situation, and it's therefore difficult to deny the worth of a facility that prevents overdose deaths.
It's surprising, then, that despite the existence of some 65 supervised injection facilities throughout the world, there has been little solid research assessing the sites' ability to prevent overdose deaths. Fortunately, though, the prestigious medical journal The Lancet has today published a paper by researchers at the B.C. Centre for Excellence in HIV/AIDS, and the paper provides precisely the evidence we need.
See full story:
http://www.vancouversun.com/Will+dramatic+drop+overdose+deaths+enough+save+Insite/4632871/story.html






